'Consolidated
net sales (including other operating income) of Atul has increased 1.42% to Rs
1212.15 crore. Sales of Life Science
Chemicals segment has gone down 7.80% to Rs 376.68 crore (accounting for 29.65%
of total sales). Sales of Performance
& Other Chemicals segment has gone up 4.78% to Rs 869.59 crore (accounting
for 68.45% of total sales). Sales of
Others segment rose 85.31% to Rs 24.09 crore (accounting for 1.90% of total
sales). Inter-segment sales rose Rs
56.31 crore to Rs 58.21 crore.
Profit
before interest, tax and other unallocable items (PBIT) has slumped 25.94% to
Rs 79.54 crore.
PBIT of Life Science
Chemicals segment fell 26.42% to Rs 66.67 crore (accounting for 83.82% of total
PBIT). PBIT of Performance & Other
Chemicals segment fell 18.25% to Rs 12.86 crore (accounti...
Pleaselogin & subscribe to view the full report.
More Reports
-
(01-Mar-2025)
Foseco India
OP up 17%
-
(28-Feb-2025)
Schaeffler India
Maintains double digit revenue growth and stable OPM
-
(28-Feb-2025)
Sanofi India
OP up 18.78%
-
(28-Feb-2025)
KSB
Net up 33% largely on higher sales, higher OI and lower taxation
|
|